Quote | Vera Therapeutics Inc. (NASDAQ:VERA)
Last: | $36.02 |
---|---|
Change Percent: | 2.3% |
Open: | $36.54 |
Close: | $36.02 |
High: | $37.2603 |
Low: | $35.06 |
Volume: | 648,198 |
Last Trade Date Time: | 06/14/2024 03:00:00 am |
News | Vera Therapeutics Inc. (NASDAQ:VERA)
BRISBANE, Calif., June 11, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced the appointment of Christy ...
2024-05-28 10:10:24 ET More on Vera Therapeutics Vera Therapeutics: Waiting For A Pullback Top 10 best performing biotech stocks of 2024 so far Seeking Alpha’s Quant Rating on Vera Therapeutics Historical earnings data for Vera Therapeutics Fin...
Message Board Posts | Vera Therapeutics Inc. (NASDAQ:VERA)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $VERA News Article - Vera Therapeutics Completes Patient Enrollment in Phase 2b ORIGIN | whytestocks | investorshangout | 07/06/2022 2:40:53 PM |
whytestocks: $VERA News Article - Vera Therapeutics Announces Closing of Upsized Public Offering of | whytestocks | investorshangout | 02/14/2022 9:30:49 PM |
whytestocks: $VERA News Article - Vera Therapeutics Hosting Key Opinion Leader Webinar on IgA Nephro | whytestocks | investorshangout | 09/09/2021 5:40:58 PM |
Stock_Tracker: Latest Veramark Techs Inc (VERA) Headlines Calero Software is Launched from the Merge | Stock_Tracker | investorshangout | 03/12/2014 4:42:37 AM |
$VERA: Merged with TEM Holdings Inc. for $1.18 | Renee | investorshub | 07/22/2013 11:33:11 PM |
News, Short Squeeze, Breakout and More Instantly...
Vera Therapeutics Inc. Company Name:
VERA Stock Symbol:
NASDAQ Market:
BRISBANE, Calif., June 11, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (NASDAQ:VERA), a late clinical-stage biotechnology company focused o...
BRISBANE, Calif., June 11, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced the appointment of Christy ...
BRISBANE, Calif., June 07, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (NASDAQ:VERA), a late clinical-stage biotechnology company focused o...